Shareprice
17 Apr 2026

Press & news

FluoGuide develops surgical solutions that are expected to reduce suffering for the patient and increase the likelihood of cure as well as reducing costs for the health care system.

New - New exchange: Nasdaq First North

FluoGuide is moving from Spotlight to Nasdaq First North. Shareholders are strongly encouraged to make sure they will be able to freely trade their shares in the future.

2019

31 May, 2019 Interim Report First Quarter 2019 for FluoGuide News English Regulatory Listing Regulation Report Interim Q1 IR
Morten Albrechtsen, CEO of FluoGuide, comments: “Not even a month has passed since FluoGuide’s very successful IPO and...
7 May, 2019 First day of trading in FluoGuide’s shares and warrants at Spotlight Stock Market News Corporate Information Other Corporate Information English IR
Ahead of the listing at Spotlight Stock Market, FluoGuide has conducted a successful IPO which has provided the company approx. DKK...
17 April, 2019 FluoGuide’s IPO significantly oversubscribed News Corporate Information Other Corporate Information English Regulatory MAR IR
The subscription period expired on 15 April 2019, for FluoGuide’s unit issue of initially approx. DKK 15.9 million (incl. compensatory...
1 April, 2019 FluoGuide’s IPO prior to listing at Spotlight Stock Market commences today News Corporate Information Other Corporate Information English IR
Subscription period: April 1st – April 15th, 2019. Subscription price: DKK 14.85 per unit. One (1) unit consists of three (3)...
Previous

FluoGuideCalendar & events

Full calendar
Cookies
We serve cookies. If you think that's ok, just click "Accept all". You can also choose what kind of cookies you want by clicking "Settings". Read our cookie policy
Settings Accept all
Cookies
Choose what kind of cookies to accept. Your choice will be saved for one year. Read our cookie policy
Save Accept all